The DISCOVER Trial represents a major advancement in HIV prevention research, offering valuable insight into new options for individuals at risk of HIV (1,2). Sponsored by Gilead Sciences, the trial explored how different PrEP medications perform in real-world settings, focusing on their safety, effectiveness, and user adherence( 1–3). As part of G
469 Reached2 Comments
ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes
Catheter Ablation for Atrial Fibrillation with HF
691 Reached
Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes
FOURIER Trial: Efficacy of Evolocumab in Managing Cardiovascular Events
563 Reached3 Comments
Safe Ramadan Practices during COVID-19 - WHO Guidance
4832 Reached8 Comments3 Likes